Tech Company Financing Transactions
Lighthouse Pharmaceuticals Funding Round
Lighthouse Pharmaceuticals, based in Novato, secured $12 million from Double Point Ventures and private investors.
Transaction Overview
Company Name
Announced On
4/28/2026
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Double Point Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support advancement of Lighthouse's lead program, LHP588, and continued pipeline expansion.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8001 Redwood Blvd
Novato, CA 94945
USA
Novato, CA 94945
USA
Phone
Undisclosed
Website
Email Address
Overview
We have a decade of data informing our strategy including patient responder analyses, rigorous dose modeling and flawless clinical execution. As a result, our therapeutic candidates have maximum potential for patient impact. Find out more about the SPRING trial for P. gingivalis positive Alzheimer's disease. Lighthouse is developing novel, potent and selective protease inhibitors based on precision medicine for major unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Casey Lynch
Chief Marketing Officer
Michael Detke
Chief Scientific Officer
Stephen Dominy
VP - Bus. Development
Joanna Bolger
VP - Manufacturing
Katie Brown
Browse more venture capital transactions:
Prev: 4/28/2026: AdJane venture capital transaction
Next: 4/28/2026: Audion venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs